ロード中...
Development of Potent Myostatin Inhibitory Peptides through Hydrophobic Residue-Directed Structural Modification
[Image: see text] Myostatin, a negative regulator of skeletal muscle growth, is a promising target for treating muscle atrophic disorders. Recently, we discovered a minimal myostatin inhibitor 1 (WRQNTRYSRIEAIKIQILSKLRL-amide) derived from positions 21–43 of the mouse myostatin prodomain. We previou...
保存先:
| 出版年: | ACS Med Chem Lett |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Chemical
Society
2017
|
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5512132/ https://ncbi.nlm.nih.gov/pubmed/28740611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.7b00168 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|